Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | -0.57% | 93.76 | 1.3% | $1006.11m | |
| BIIB | Biogen Inc. | -0.35% | 226.39 | 1.3% | $952.73m | |
| AMGN | Amgen Inc. | -2.74% | 177.47 | 1.3% | $455.04m | |
| GILD | Gilead Sciences, Inc. | -0.47% | 62.95 | 0.9% | $420.88m | |
| ILMN | Illumina, Inc. | 0.11% | 319.03 | 3.5% | $281.15m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -2.81% | 333.34 | 2.6% | $259.19m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.71% | 168.16 | 1.9% | $237.18m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.08% | 126.01 | 2.0% | $169.88m | |
| ONCE | Spark Therapeutics, Inc. | -0.08% | 110.62 | 11.2% | $168.64m | |
| EXAS | Exact Sciences Corporation | 0.44% | 92.21 | 25.3% | $159.86m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.76% | 116.64 | 14.7% | $145.69m | |
| A | Agilent Technologies, Inc. | 0.99% | 76.18 | 1.6% | $128.52m | |
| INCY | Incyte Corporation | -0.48% | 73.96 | 2.5% | $95.36m | |
| IONS | Ionis Pharmaceuticals, Inc. | 0.44% | 72.99 | 8.3% | $93.24m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.98% | 83.16 | 4.3% | $89.86m |
Company Profile
Actinium Pharmaceuticals, Inc. is a clinical-stage, Biopharmaceutical Company focused on developing and potentially commercializing therapies to cell therapies. The firm's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells. Its product pipeline includes Iomab-B, Actimab-A, and Actimab-M. The company was founded in 1993 and is headquartered in New York, NY.